Palisade BIO, Inc (PALI) insider trading

Every open-market stock purchase and sale by Palisade BIO, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Donald Allen Williams (Director) bought $28.8K in the last 90 days.

Last 12 months: insiders bought $297K (6 buys) and sold $420K (4 sales). Last close $1.35 on Oct 22, 2026.

Recent PALI insider trades

DateInsiderTradeValue
Oct 19, 2026Julien E. Capers (Officer)Bought (not open market)—
Oct 6, 2026John David Finley (CEO)Sold (not open market)$2.1M
Oct 6, 2026Mitchell Lawrence Jones (Officer)Sold (not open market)$1.5M
Oct 6, 2026Mitchell Lawrence Jones (Officer)Bought (not open market)—
Oct 6, 2026John David Finley (CEO)Bought (not open market)—
Oct 6, 2026John David Finley (CEO)Bought (not open market)—
Oct 6, 2026John David Finley (CEO)Bought (not open market)—
Oct 6, 2026Mitchell Lawrence Jones (Officer)Bought (not open market)—
Oct 6, 2026Mitchell Lawrence Jones (Officer)Bought (not open market)—
Oct 2, 2026Donald Allen Williams (Director)Bought$14.6K
Oct 1, 2026Donald Allen Williams (Director)Bought$14.2K
Aug 19, 2026John David Finley (CEO)Sold (not open market)—
Aug 19, 2026John David Finley (CEO)Bought (not open market)—
Jul 9, 2026Robert Baltera Jr. (Director)Bought$48.9K
Jul 8, 2026Robert Baltera Jr. (Director)Bought$39.8K
Jul 7, 2026John David Finley (CEO)Sold$303K
Jul 7, 2026Mitchell Lawrence Jones (C-suite exec)Sold$107K
Jul 7, 2026Robert Baltera Jr. (Director)Bought$61K
Jul 7, 2026John David Finley (CEO)Bought (not open market)$93
Jul 7, 2026John David Finley (CEO)Bought (not open market)—
Jul 6, 2026Robert Baltera Jr. (Director)Bought$41K
Jul 6, 2026John David Finley (CEO)Bought (not open market)—
Jul 6, 2026Mitchell Lawrence Jones (C-suite exec)Bought (not open market)—
Jul 6, 2026Mitchell Lawrence Jones (C-suite exec)Bought (not open market)—
Jul 6, 2026John David Finley (CEO)Bought (not open market)—

Who's trading PALI

Get free alerts when an insider at Palisade BIO, Inc files a new trade →